Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other financing activities (2025)

Metagenomi (MGX) has disclosed Other financing activities for 1 consecutive years, with $19000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to $19000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $558000.0, a N/A change, with the full-year FY2025 number at $558000.0, changed N/A from a year prior.
  • Other financing activities was $19000.0 for Q4 2025 at Metagenomi, down from $187000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $275000.0 in Q2 2025 to a low of $19000.0 in Q4 2025.